08.05.2017 • News

SABIC Invests in Composites Specialist

Airborne International © All rights reserved
Airborne International © All rights reserved

Saudi chemicals giant SABIC has invested an undisclosed sum in Dutch composites specialist Airborne International as part of a growth financing round by existing shareholders. The funds will allow Airborne to implement digital infrastructure that will serve as a platform for automating thermoplastic composites production, which will improve yields, cycle times and system costs.

SABIC said the move is a critical step towards a broader use of continuous fiber-reinforced composites and offers the opportunity to achieve mass production in a more cost-effective way. “This investment and collaboration with Airborne will enable SABIC to take the next step in the commercialization of thermoplastic composites and help our customers to develop unique lightweight applications,” said Ernesto Occhiello, executive vice president of SABIC’s Specialties business.

Airborne’s founder and CEO, Arno van Mourik, added that a radical increase in the level of automation and digitalization as well as the availability of information throughout the supply chain will be crucial success factors for the composites industry.

Fiber-reinforced thermoplastic composites offer the potential for many industries, including aerospace, automotive, oil & gas, consumer electronics and sport, to make components that require less weight but higher strength than alternative materials.

In March 2016, SABIC took a majority stake in Dutch company Fibre Reinforced Thermoplastics, a producer of unidirectional (UD) tape used in applications ranging from building and construction to transportation and energy. The tapes can be formed into composite materials.

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.